GenHealth.ai, a healthcare artificial intelligence company focused on running the medical back office, announced a $16.5 million Series A funding round led by Flare Capital Partners. Existing investors Craft Ventures and Obvious Ventures joined the round, alongside new investors Eniac Ventures, InHealth Ventures, Epsilon Health Investors, and ARTIS. The investment brings the company's total funding to $30 million.
Addressing a Trillion Dollar Administrative Burden
The United States spends roughly one trillion dollars per year on healthcare administration, and much of that work remains manual across systems that do not connect. Getting care approved and paid for involves hundreds of actions across electronic health records, payer portals, fax lines, and phone calls. Those bottlenecks delay treatment for patients and leave providers and suppliers chasing revenue they have already earned.
How GenHealth AI Agents Work
GenHealth's AI agents connect the systems a practice already uses and carry administrative work through to completion. They manage intake, eligibility verification, prior authorization, billing, denials, and custom workflows end to end inside EHRs, payer portals, fax, and phone systems. A practice brings the platform on like a new hire, with staff showing agents their workflows and creating user accounts before go-live, while GenHealth's U.S.-based billing team handles exceptions and staff stay involved for judgment calls.
Leadership and Model Foundation
GenHealth was founded in 2023 by Ricky Sahu and Ethan Siegel after Sahu spent a decade building interoperability APIs at 1upHealth and CareJourney. Its agents run on a Large Medical Model trained on coded claims and clinical histories from more than 140 million patients. Sahu said the key problem was not the AI itself but connecting AI to systems like EHRs, plan portals, fax, and bank accounts, which helps patients get faster care and providers get paid over 30 percent.
Investor Perspective
Flare Capital Partners Partner Vic Lanio said provider organizations do not need another system of record but need the work done. He described GenHealth as more than agentified SaaS because its agents work alongside humans in existing systems to complete tasks. This operational focus, he added, is why Flare led the round.
Customer Validation
Jack Bachman, CEO and owner of Piedmont Medical Solutions, said his organization transitioned to GenHealth for full-service intake and billing and could not be happier. He noted the AI-driven process automated more work with better results than a previous outsourced team five times its size. Bachman also highlighted the company's U.S.-based team, earlier problem detection, and transparency as key benefits.
Growth Plans and Hiring
GenHealth will use the new capital to grow its engineering and go-to-market teams, extend its agents into additional workflows for provider groups and health plans, and continue improving the underlying model. The company has grown to more than 20 employees since its seed round and is hiring across engineering, operations, and go-to-market. Open roles are listed on the company's careers page at https://genhealth.ai/jobs.
The $16.5 million Series A highlights investor confidence in AI agents that complete administrative work inside existing healthcare systems rather than adding new software. With total funding of $30 million, GenHealth is positioned to expand its capabilities and customer base across medical groups, durable medical equipment suppliers, and health plans. Its focus on workflow execution and measurable revenue gains could help address one of the most persistent cost centers in American healthcare.